Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate

Journal of Investigative Dermatology

Volumn 126, Issue 2, 2006, Pages 265-271

  Angell Petersen, Even ^a   Sørensen, Roar ^a   Warloe, Trond ^a   Soler, Ana Maria ^a   Moan, Johan ^a   Peng, Qian ^a   Giercksky, Karl Erik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; PORPHYRIN; WATER OIL CREAM;

ACTINIC KERATOSIS; AGED; AREA UNDER THE CURVE; ARTICLE; BASAL CELL CARCINOMA; BIOACCUMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG FORMULATION; DRUG TISSUE LEVEL; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; MALE; PHOTOSENSITIZATION; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; AGED; AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KERATOSIS; MALE; MICROSCOPY, FLUORESCENCE; MONITORING, PHYSIOLOGIC; OINTMENTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 33644661677     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700048     Document Type: Article

References (42)

1. af Klinteberg C, Ejder AM, Wang I, Andersson-Engels S, Svanberg S, Svanberg K (1999) Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas. J Photochem Photobiol B 49:120-8
2. Berner A, Soler A, Warloe T (1999) Skin scrape cytology in the diagnosis of nodular basal cell carcinoma for treatment by photodynamic therapy. Acta Derm Venereol 79:147-9
3. Braathen L, Paredes B, Frölich K, Wijnen I, Warloe T, Fritsch C et al. (2000) A dose finding study of photodynamic therapy with metvix® in actinic keratosis. J Eur Acad Dermatol Venereol 14(suppl 1):38(abstr.)
4. Bigelow CE, Mitra S, Knuechel R, Foster TH (2001) ALA- and ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroids. Br J Cancer 85:727-34
5. Casas A, Perotti C, Fukuda H, Rogers L, Butler AR, Batlle A (2001) ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization. Br J Cancer 85:1794-800
6. de Rosa FS, Tedesco AC, Lopez RF, Pierre MB, Lange N, Marchetti JM et al. (2003) In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. J Control Release 89:261-9
7. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M et al. (1998) Photodynamic therapy. J Natl Cancer Inst 90:889-905
8. Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P et al. (2003) A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 14:99-106
9. Fritsch C, Homey B, Stahl W, Lehmann P, Ruzicka T, Sies H (1998) Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol 68:218-21
10. Gaullier JM, Berg K, Peng Q, Anholt H, Selbo PK, Ma LW et al. (1997) Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 57:1481-6
11. Golub AL, Gudgin DE, Kennedy JC, Marcus SL, Park Y, Pottier RH (1999) The monitoring of ALA-induced protoporphyrin IX accumulation and clearance in patients with skin lesions by in vivo surface-detected fluorescence spectroscopy. Lasers Med Sci 14:112-22
12. Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes LE et al. (2003) Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 149:1242-9
13. Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6:143-8
14. Kloek J, Beijersbergen VH (1996) Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 64:994-1000
15. Lange N, Jichlinski P, Zellweger M, Forrer M, Marti A, Guillou L et al. (1999) Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer 80:185-93
16. Lopez RF, Lange N, Guy R, Bentley MV (2004) Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv Drug Deliv Rev 56:77-94
17. Malik Z, Lugaci H (1987) Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer 56:589-95
18. Martin A, Tope WD, Grevelink JM, Starr JC, Fewkes JL, Flotte TJ et al. (1995) Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res 287:665-74
19. Moan J, Ma LW, Iani V (2001) On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters. Int J Cancer 92:139-43
20. Moan J., Hrkal Z., Peng Q., Ma L.W., Warloe T, Heyerdahl H (1995) Measurements of sensitizer fluorescence in patients by means of an ordinary fluorescence spectrometer. Proc Int Soc Opt Eng 2371:516-519
21. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H et al. (2002) Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146:552-67
22. Newell B, Bedlow AJ, Cliff S, Drysdale SB, Stanton AW, Mortimer PS (2003) Comparison of the microvasculature of basal cell carcinoma and actinic keratosis using intravital microscopy and immunohistochemistry. Br J Dermatol 149:105-10
23. Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ et al. (2003) Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 48:227-32
24. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM (1997) 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 65:235-51
25. Peng Q, Evensen JF, Rimington C, Moan J (1987) A comparison of different photosensitizing dyes with respect to uptake C3H-tumors and tissues of mice. Cancer Lett 36:1-10
26. Peng Q, Moan J, Nesland JM (1996) Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct Pathol 20:109-29
27. Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE (2001) Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 62:140-5
28. Peng Q, Warloe T, Moan J, Heyerdahl H, Steen HB, Nesland JM et al. (1995) Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 62:906-13
29. Perotti C, Casas A, Fukuda H, Sacca P, Batlle A (2002) ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice. Br J Cancer 87:790-5
30. Pottier RH, Chow YF, LaPlante JP, Truscott TG, Kennedy JC, Beiner LA (1986) Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem Photobiol 44:679-87
31. Rhodes LE, de Rie M, Enstrom Y, Groves R, Morken T, Goulden V et al. (2004) Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 140:17-23
32. Rud E, Gederaas O, Hogset A, Berg K (2000) 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 71:640-7
33. Sinaasappel M, Sterenborg HJCM (1993) Quantification of the hematoporphyrin derivative by fluorescence measurement using dual-wavelength excitation and dual-wavelength detection. Applied Optics 32:541-8
34. Soler AM, Warloe T, Berner A, Giercksky KE (2001) A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 145:467-71
35. Soler AM, Warloe T, Tausjo J, Berner A (1999) Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol 79:204-6
36. Svaasand LO, Wyss P, Wyss MT, Tadir Y, Tromberg BJ, Berns MW (1996) Dosimetry model for photodynamic therapy with topically administered photosensitizers. Lasers Surg Med 18:139-49
37. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C et al. (2002) Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 47:258-62
38. Thompson MS, Gustafsson L, Palsson S, Bendsoe N, Stenberg M, Klinteberg CA et al. (2001) Photodynamic therapy and diagnostic measurements of basal cell carcinomas using esterified and non-esterified delta-aminolevulinic acid. J Porphyrins Phthalocyanines 5:147-53
39. Tunstall RG, Barnett AA, Schofield J, Griffiths J, Vernon DI, Brown SB et al. (2002) Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo. Br J Cancer 87:246-50
40. van den Akker JT, Holroyd JA, Vernon DI, Sterenborg HJ, Brown SB (2003) Comparative in vitro percutaneous penetration of 5-aminolevulinic acid and two of its esters through excised hairless mouse skin. Lasers Surg Med 33:173-81
41. Wiegell SR, Stender IM, Na R, Wulf HC (2003) Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 139:1173-7
42. Wolf P, Rieger E, Kerl H (1993) Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol 28:17-21